Clinical Trials Logo

Clinical Trial Summary

Propofol is one of the most commonly used anesthetics in the world. However, the dose-response of propofol was remarkable variety. Herein, this study aims to investigate the possible association of gene polymorphism and propofol susceptibility, and to research more precise infusion model of this drug.


Clinical Trial Description

Patients undergoing gastrointestinal endoscopy will be recruited. Anesthesia is induced with propofol via TCI at 1.5µg/ml, and increases 0.5µg/ml for every 3min until OAA/S score 0. During this period, OAA/S score will be evaluated every 1min until OAA/S score 0. At this moment, the blood concentration of propofol, the doses of propofol, the onset time and BIS are recorded, and blood sample for gene polymorphism detection were required. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05158426
Study type Observational
Source West China Hospital
Contact
Status Completed
Phase
Start date November 20, 2019
Completion date November 18, 2021

See also
  Status Clinical Trial Phase
Completed NCT04520503 - Relationship Between Pre-induction Electroencephalogram Pattern of Adult Patients and Their Sensitivity to Propofol
Completed NCT02199522 - Clinical Observation of Titration Induction and Convention Induction of Propofol N/A
Completed NCT01435785 - Performance Evaluation of Four Pharmacokinetic-Pharmacodynamic(PKPD) Models of Propofol in Elderly Patients N/A